ICIBS Trial - Improving Patient Information About Bowel Cancer Screening - a Decision Aid Trial

This study has been completed.
Information provided by:
University of Sydney
ClinicalTrials.gov Identifier:
First received: September 5, 2005
Last updated: January 3, 2006
Last verified: September 2005

This project has been completed and consisted of a randomised trial of six tailored decision aids giving patients evidence-based information about faecal occult blood test screening for bowel cancer. 314 Australians aged between 50-74 years were recruited from five general practices and randomised to received either the tailored decision aid with age-gender and family history specific information and values clarification exercise or a standard government information sheet.

The decision aid significantly increased the proportion of people who were informed participants in the screening program.

Condition Intervention Phase
Colorectal Cancer Screening
Behavioral: Decision Aid
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Educational/Counseling/Training
Official Title: Randomized Controlled Trial of Patient Decision Aids for Faecal Occult Blood Test Screening

Resource links provided by NLM:

Further study details as provided by University of Sydney:

Study Start Date: November 2003
Estimated Study Completion Date: September 2005

Ages Eligible for Study:   50 Years to 74 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • People aged 50-74 years who were eligible for FOBT screening under current Australian guidelines and had not had screening for colorectal cancer in the preceding two years

Exclusion Criteria:

  • Poor English, impaired cognition, significant comorbidity
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00148226

Australia, New South Wales
University of Sydney
Sydney, New South Wales, Australia, 2006
Sponsors and Collaborators
University of Sydney
Principal Investigator: Lyndal J Trevena, MBBS University of Sydney
Study Director: Les Irwig, PhD University of Sydney
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00148226     History of Changes
Other Study ID Numbers: 211205 
Study First Received: September 5, 2005
Last Updated: January 3, 2006
Health Authority: Australia: National Health and Medical Research Council

Keywords provided by University of Sydney:
Decision Aid
Faecal Occult Blood Test
Colorectal Cancer Screening
Informed Decision-making

Additional relevant MeSH terms:
Colorectal Neoplasms
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms by Site
Rectal Diseases

ClinicalTrials.gov processed this record on May 22, 2016